Literature DB >> 2200683

Prodrugs for the improvement of drug absorption via different routes of administration.

L P Balant1, E Doelker, P Buri.   

Abstract

The authors critically review recent knowledge on the use of prodrugs to improve drug absorption. Main emphasis is placed on the parenteral, oral, transdermal and ocular routes. Mechanisms for drug absorption enhancement and bioavailability assessment are discussed. Some other applications of prodrugs are also examined. Finally, some comments are made regarding the present situation and future trends in prodrug design and their implications in biopharmaceutics and pharmacokinetics.

Mesh:

Substances:

Year:  1990        PMID: 2200683     DOI: 10.1007/BF03190197

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  61 in total

1.  Prodrug approaches to enhancement of physicochemical properties of drugs IV: novel epinephrine prodrug.

Authors:  A Hussain; J E Truelove
Journal:  J Pharm Sci       Date:  1976-10       Impact factor: 3.534

2.  Isomerization of cephalosporin esters: implications for the prodrug ester approach to enhancing the oral bioavailabilities of cephalosporins.

Authors:  A N Saab; L W Dittert; A A Hussain
Journal:  J Pharm Sci       Date:  1988-10       Impact factor: 3.534

3.  Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid.

Authors:  A J Aguiar; J E Zelmer
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

4.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development.

Authors:  C D Yu; J L Fox; N F Ho; W I Higuchi
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

5.  Improved delivery through biological membranes. 4. Prodrugs of L-dopa.

Authors:  N Bodor; K B Sloan; T Higuchi; K Sasahara
Journal:  J Med Chem       Date:  1977-11       Impact factor: 7.446

6.  Alkylating properties of phosphoramide mustard.

Authors:  M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

7.  The pharmacokinetics of heroin in patients with chronic pain.

Authors:  C E Inturrisi; M B Max; K M Foley; M Schultz; S U Shin; R W Houde
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

8.  Prodrugs of 6-thiopurines: enhanced delivery through the skin.

Authors:  K B Sloan; M Hashida; J Alexander; N Bodor; T Higuchi
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

9.  Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters.

Authors:  H Bundgaard; E Falch; C Larsen; G L Mosher; T J Mikkelson
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

10.  Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.

Authors:  J T Burke; W A Wargin; R J Sherertz; K L Sanders; M R Blum; F A Sarubbi
Journal:  J Pharmacokinet Biopharm       Date:  1982-12
View more
  3 in total

1.  In vitro evaluation of polymerized liposomes as an oral drug delivery system.

Authors:  J Okada; S Cohen; R Langer
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

2.  Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.

Authors:  Kunan Bangphumi; Chuleeporn Kittiviriyakul; Pasarapa Towiwat; Pornchai Rojsitthisak; Phisit Khemawoot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

3.  Absorption of ester prodrugs in Caco-2 and rat intestine models.

Authors:  Xin He; Mitsuru Sugawara; Yoh Takekuma; Katsumi Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.